Release Date: 07/10/10 13:08 Summary: Broker Presentation - Amendment to CPS Price Sensitive: No Download Document 6.85MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%